Department of Defense Critical Reagents Program seeking biological sampling kits
The CRP works to create high quality, validated and standardized biological detection assays and reagents for military and biological defense. The company facilitates the transition of new technologies and coordinates their advanced development, efficient production and timely distribution, Global Biodefense reports.
Critical reagents CRP works with include antibodies, inactivated antigens, genomic materials, electrochemiluminescence assays, polymerase chain reaction assays, lateral flow immunoassays and biological sampling kits used for the detection of Category A and B biological warfare agents. Target pathogens include C. botulinum, B. anthracis, Burkholderia, Brucella, F. tularensis, and Y. pestis.
CRP also supports manufacture, storage and distribution of consumable reagents and end items for the Joint Biological Point Detection System and the Joint Portal Shield System, as well as other hand held assays and sampling kits used for domestic preparedness, homeland defense and counterterrorist operations, Global Biodefense reports.
The government is soliciting information from qualified companies in the areas of immunoassay and reagent evaluation and testing; product stability and accelerated shelf life testing; immunoassay and reagent evaluation and testing; verification testing on lateral flow immunoassays, including, but not limited to, sensitivity, false positive reactions, dose response curves, cross-reactivity to near neighbors/battlefield interferents, and physical specification inspection; verification testing on electrochemiluminescence assays, including, but not limited to, signal to noise ratio, sensitivity and false positive ration; verification testing on ECL system reagents, including, but not limited to, pH, appearance, surfactant concentration, physical inspection, conductivity and hypochlorite testing; and testing on ECL positive controls to verify controls perform within acceptable ranges based on conformance criteria.
The request for information is for planning purposes only. The plan will have an estimated dollar value of no more than $2 million over a two year period, according to Global Biodefense.